Back to search

Article

Standard treatment against paediatric BRAF-V600E glioma promotes senescence and sensitizes tumours to BCL-xL inhibition

2026-01-14

Abstract excerpt

<h4>Background</h4> Chemo-, radio-, and targeted therapies can induce senescence in tumour cells, a process called therapy-induced senescence (TIS), which can be exploited therapeutically using compounds that kill senescent cells (senolytics). Children with BRAF-V600E activated brain tumours are commonly treated with Dabrafenib, Trametinib or Vinblastine (alone or in combination) with good responses. However, a s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2cc41b4c-b697-5d4b-8b1c-80b5e4a0c036
DOI
10.64898/2026.01.13.698644
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Standard treatment against paediatric BRAF-V600E glioma promotes senescence and sensitizes tumours to BCL-xL inhibitionDOI 10.64898/2026.01.13.698644
Select a neighboring publication to make it the new centre.